Millbrae, CA, United States of America

Xunshan Ding

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • San Bruno, CA (US) (2018 - 2020)
  • Millbrae, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Xunshan Ding

Introduction: Xunshan Ding is a prominent inventor based in Millbrae, California, known for his significant contributions to the field of biotechnology. He holds four patents, showcasing his innovative approaches to medical science, particularly in the development of antibodies.

Latest Patents: Among his latest inventions are two noteworthy patents focusing on methods of lowering triglyceride levels. The first patent describes methods utilizing an ANGPTL8-binding antibody or antigen-binding fragment to target Angiopoietin-like protein 8 (ANGPTL8). The second patent similarly details ANGPTL8-binding agents and their specific binding capabilities, emphasizing their potential therapeutic uses for human health.

Career Highlights: Xunshan Ding is associated with Ngm Biopharmaceuticals, Inc., where he applies his expertise in biotechnology to further research and development. His groundbreaking work in creating binding agents aims to address critical health issues, contributing to advancements in therapeutic solutions.

Collaborations: In his professional journey, Xunshan Ding has collaborated with notable coworkers such as Zhonghao Liu and Chun Chu. Together, they have worked on various innovative projects that push the boundaries of current medical knowledge and applications.

Conclusion: Xunshan Ding exemplifies the spirit of innovation and collaboration in the biotechnology sector. His patents and ongoing work at Ngm Biopharmaceuticals, Inc. highlight his vital role in developing novel solutions to health challenges, solidifying his position as a key inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…